Jori

Jori

Hospitals and Health Care

Hoboken, New Jersey 99 followers

Flattening the healthcare triangle. One record at a time.

About us

Jori helps patients, providers, & scientists win the battle against cancer by bringing population scale oncology data on-chain.

Website
https://www.jori.health
Industry
Hospitals and Health Care
Company size
2-10 employees
Headquarters
Hoboken, New Jersey
Type
Privately Held

Locations

Employees at Jori

Updates

  • "How on earth did my reviewer miss it? Its stated clearly on page-4. Do they not read?" 📝 When you are new to writing papers, there is a strong compulsion to write down every important thought as they appear in whatever section you are currently writing at that time. 👻 Soon, your results are in intro, literature survey in results, plots appear first followed next by nuances in the experimental methodology used. 🙃 All of this puts the burden on the reviewer to extract details from parts of your paper.The result? Reviewers get tired and click reject. ⛔ It does not matter how good your work is. If you can’t put information where the reader expects to find it, your work will never see the light of the day. Handy guide attached for getting this right. If you are working on cancer cure, try Tailwind >> https://buff.ly/3VczfdZ

    • No alternative text description for this image
  • Join in on December 20! Videocast option also available ⬇️

    🗓 UPCOMING EVENT: Join us for the next seminar in our 2024 Grand Rounds Lecture Series with Anish Thomas, MBBS, M.D., Senior Investigator in our Developmental Therapeutics Branch! Anish Thomas, MBBS, M.D., is a medical oncologist who specializes in the treatment of thoracic cancers. His research focuses on small-cell lung cancer (SCLC), the most fatal and highly metastatic form of lung cancer which kills at least 200,000 people globally each year, including approximately 30,000 individuals in the United States. ➡ If you cannot attend in person, this lecture will also be available for viewing the day of on the NIH VideoCast: https://videocast.nih.gov/ National Cancer Institute (NCI), National Institutes of Health (NIH): Intramural Research Program (IRP), NIH Clinical Center (CC), Anish (NIH/NCI) Thomas

    • No alternative text description for this image
  • We’ve downloaded AND read them all. If you are curing cancer, let’s start writing. Tailwind lets you: 💡 come up with high impact ideas that are right for YOU + your lab 📚 comprehensive literature review for all things cancer (yeah, we read it all) 🔬experimental methodology catered to your lab 📝 first drafts that are so polished you'd probably cry ⏩ Get some Tailwind https://buff.ly/3D03QFG

    • No alternative text description for this image
  • These tips 3x the chances of your paper getting accepted. After reviewing 100s of papers and talking to peers who reviewed 1000s - these are patterns that simplify writing and make your reviewers journey easy. (Wish this advice is commonplace, esp for new comers) 1. Active voice sells ideas better than passive. Always. 2. Live for your OWN truth, never for other scholars' approval 3. Write the methods section before conducting experiments 4. Break complex ideas into simple formal language 5. Citations should be a taste of truth → use them thoroughly 6. Your abstract is your paper's movie trailer 7. The discussion isn't a results remix → this is where you DISARM your reviewers by going through potential objections one by one 8. Tables whisper wisdom that paragraphs shout gruffly 9. No one reads your paper start to finish → always design for skimming. Pay attention to section titles, sub-sections, figure captions, and literally anything that sticks out like barbs to help the scan. 10. My best writing happens between 5 AM - 10 AM. Find yours. 11. Your title is not unrelated to your citation success 12. Tweak tenaciously → cut 30% of your first draft. And then, some more. 13. Strong verbs always beat fancy adjectives 14. Make text-to-speech AI your read-aloud buddy 15. One paragraph = one idea (NO exceptions) ⏩ Tailwind avoids these mistakes. If you are curing cancer, we got you covered https://buff.ly/3D03QFG

    • No alternative text description for this image
  • The peer-review process has slowly curated a level of perversion in the publication industry that is hard to ignore. If you have reviewed over a 100 submissions, and received some the most bizarre reviewer#2’s for years, it slowly sinks in. This actually got published. See for yourself —>

    https://t.co/s3pyrv16rR

    https://t.co/s3pyrv16rR

  • Of the 18.1 million Cancer Survivors in the US, nearly half have lived 10 or more years after their diagnosis, while 19% have lived 20 or more years, as reported in a JNCI Now study led by NCI researchers. These stats are truly encouraging and highlight the progress in cancer research and treatment. It's inspiring to see such significant survival rates among cancer survivors. The next decade will usher precision medicine. Cannot wait for survivorship to rise even further. The future is bright. Source: https://buff.ly/4ilj4Fa

    • No alternative text description for this image
  • Congrats to all newly matched 2025 hem-onc fellows 🎉

    The National Institutes of Health is pleased to announce our newly matched 2025 hematology-oncology fellows! The National Cancer Institute (NCI) fellows & their internal medicine residency programs are Drs. Cynthia Eleanya (Johns Hopkins Bayview Medical Center), Seyma Eroglu (Weiss Memorial Hospital), Sean Evans (Emory University Hospital), Allison Graeter (USF Health), Kamilia Moalem (Jackson Health System), & Haitao Xu, MD, MSGM (UT Southwestern Medical Center). Dr. Ian Schonman (Johns Hopkins Hospital) is our NCI Cancer Prevention fellow. Our new National Heart, Lung, and Blood Institute fellows are Drs. Samuel Kosydar (Mayo Clinic Rochester), Sebastian Mendez Marti (Inova Fairfax Hospital) & Rachel Zemel (MedStar Georgetown University Hospital. We welcome all to the NIH Clinical Center (CC)! ➡️ Learn more about the NIH Hematology Oncology Fellowship: https://go.nih.gov/sWvfJbB

    • This image is a grid of headshots of all 10 individuals mentioned in this post.
  • How to write a good grant? 1. Write it for the reviewer, not you, the applicant. 2. Communicate in stories. 3. Make your story cohesive—leave no puzzling gaps. 4. Make your story resonate to keep the reviewer reading. 5. Accept chance and noise in peer-review.

    • No alternative text description for this image
  • Advancing drug discovery hinges upon our ability to predict cellular responses to new compounds. 🧪 This is massively time intensive. There simply aren’t enough traditional labs & resources needed to endlessly test compound combinations. 🌟 Enter PRNet - a massive step forward in Gen AI. Recently introduced in Nature Communications by Qi and coauthors, this model named PRnet leverages a perturbation-conditioned generative model—a type of model trained to generate predictions conditioned on specific perturbations, such as the introduction of a new compound. PRnet predicts transcriptional responses to novel chemical compounds across various cell types and disease pathways. Wow! But it gets better. PRnet can perform in-silico compound screening. It can also create a "perturbation atlas" that maps predicted cellular responses across 88 cell lines, 52 tissues, and tens of thousands of compounds. https://buff.ly/49iEe2B

    • No alternative text description for this image

Similar pages